Epalinges
Switzerland
12
2024-11-21
3
2024-06-18
These are the the leading inventors for applications assigned to NUVAMID SA:
NUVAMID SA based in Epalinges, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION
#2 | 2024-10-10NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR USE IN THE TREATMENT OF SAPHO SYNDROME
#3 | 2024-04-18USE OF NICOTINAMIDE MONONUCLEOTIDE (NMN) FOR THE PREVENTION AND/OR TREATMENT OF RHEUMATOID ARTHRITIS, AND CORRESPONDING COMPOSITIONS
#4 | 2023-11-09 ✅ Patent 12,011,454 granted on 2024-06-18Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of a red blood cell disorder
#5 | 2023-10-19 ✅ Patent 12,403,153 granted on 2025-09-02NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER
#6 | 2023-10-12 ✅ Patent 12,642,812 granted on 2026-06-02NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF AN ANTINEOPLASTIC-INDUCED TOXICITY
#7 | 2023-07-06NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS
#8 | 2023-06-08USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF A BACK PAIN AND CORRESPONDING COMPOSITIONS
#9 | 2023-05-18USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF MUSCLE, LIGAMENT OR TENDON PAIN INDUCED BY PHYSICAL ACTIVITY AND CORRESPONDING COMPOSITIONS
#10 | 2023-03-30NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIA
#11 | 2023-03-30NOVEL NICOTINAMIDE DI-NUCLEOTIDE DERIVATIVES AND USE THEREOF
#12 | 2023-01-05USE OF COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF ANKYLOSING SPONDYLITIS, AND CORRESPONDING COMPOSITIONS
Also check out NUVAMID SA's (Epalinges, Switzerland) applicant profile with 7 patent applications submitted.
332561 ⎘